TARDBP and frontotemporal dementia: Finally, as mentioned in our previous section, NPTX2, which is involved in synaptic plasticity, was found lower in the CSF of the symptomatic phase of FTD patients regardless of the underlying genetic mutation (C9ORF72, GRN and MAPT) and, therefore, is of yet unclear significance as TDP-43 specific biomarker [95].